Critical Review: Mirion Technologies (MIR) versus Its Competitors

Mirion Technologies (NYSE:MIR) is one of 377 publicly-traded companies in the “Electronic Equipment, Instruments & Components” industry, but how does it contrast to its rivals? We will compare Mirion Technologies to related businesses based on the strength of its institutional ownership, risk, profitability, dividends, earnings, analyst recommendations and valuation.

Institutional and Insider Ownership

78.5% of Mirion Technologies shares are owned by institutional investors. Comparatively, 43.3% of shares of all “Electronic Equipment, Instruments & Components” companies are owned by institutional investors. 6.3% of Mirion Technologies shares are owned by insiders. Comparatively, 16.4% of shares of all “Electronic Equipment, Instruments & Components” companies are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Volatility & Risk

Mirion Technologies has a beta of 1.07, indicating that its share price is 7% more volatile than the S&P 500. Comparatively, Mirion Technologies’ rivals have a beta of -0.30, indicating that their average share price is 130% less volatile than the S&P 500.

Profitability

This table compares Mirion Technologies and its rivals’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Mirion Technologies	2.69%	6.82%	3.62%
Mirion Technologies Competitors	-158.11%	-25.88%	-6.86%

Analyst Ratings

This is a breakdown of current ratings and price targets for Mirion Technologies and its rivals, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Mirion Technologies	0	2	7	1	2.90
Mirion Technologies Competitors	2047	7603	10433	662	2.47

Mirion Technologies presently has a consensus target price of $24.88, suggesting a potential upside of 44.03%. As a group, “Electronic Equipment, Instruments & Components” companies have a potential upside of 41.97%. Given Mirion Technologies’ stronger consensus rating and higher possible upside, research analysts plainly believe Mirion Technologies is more favorable than its rivals.

Valuation and Earnings

This table compares Mirion Technologies and its rivals revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Net Income	Price/Earnings Ratio
Mirion Technologies	$925.40 million	$28.80 million	143.93
Mirion Technologies Competitors	$4.13 billion	$172.92 million	4.24

Mirion Technologies’ rivals have higher revenue and earnings than Mirion Technologies. Mirion Technologies is trading at a higher price-to-earnings ratio than its rivals, indicating that it is currently more expensive than other companies in its industry.

Summary

Mirion Technologies beats its rivals on 10 of the 13 factors compared.

Mirion Technologies Company Profile

Mirion Technologies, Inc. provides radiation detection, measurement, analysis, and monitoring products and services in the United States, Canada, the United Kingdom, France, Germany, Finland, China, Belgium, Netherlands, Estonia, South Korea, and Japan. It operates through two segments, Medical and Technologies. The Medical segment offers radiation oncology quality assurance and dosimetry solutions; patient safety solutions for diagnostic imaging and radiation therapy centers; radiation therapy quality assurance solutions for calibrating and verifying imaging and treatment accuracy; and radionuclide therapy products for nuclear medicine applications, such as shielding, product handling, medical imaging furniture, and rehabilitation products. This segment supports applications in medical diagnostics, cancer treatment, practitioner safety, and rehabilitation. The Technologies segment focuses on addressing critical radiation safety, measurement, and analysis applications; and provides personal radiation detection, identification equipment, and analysis tools. The company's products and solutions also include nuclear medicines, dosimeters, contamination and clearance monitors, reactor instrumentation and control equipment and systems, medical and industrial imaging systems and related accessories, alpha spectroscopy instruments, alpha/beta counting instruments, and gamma spectroscopy detector systems; and electrical penetration, cancer diagnostics, software, and other services. It serves hospitals, clinics and urgent care facilities, dental and veterinary offices, radiation treatment facilities, OEMs for radiation therapy, laboratories, military organizations, government agencies, industrial companies, power and utility companies, reactor design firms, and NPPs. The company was formerly known as Global Monitoring Systems, Inc. and changed its name to Mirion Technologies, Inc. in January 2006. The company was incorporated in 2005 and is headquartered in Atlanta, Georgia.